Enveric Biosciences, Inc.
ENVB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000890821
No open-market purchases or sales by Enveric Biosciences, Inc. insiders were filed in the last 90 days; 24 institutions reported holding it in 13F filings for Q2 2026, worth $736.8K in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Enveric Biosciences, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 19 | 15 | −4 |
| Shares | 1.08M | 253.2K | −825.9K (−76.5%) |
| Value | $386.7K | $344.7K | −$42.0K (−10.9%) |
New holders (4)
Institutions that held Enveric Biosciences, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 40,625 | $56.0K | 0.00% |
| FMR LLC | 3,426 | $4.76K | 0.00% |
| Headlands Technologies LLC | 110 | $153 | 0.00% |
| Barclays PLC | 30 | $42 | 0.00% |
Sold out (8)
Institutions that held Enveric Biosciences, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Two Sigma Securities, LLC | 31,872 | $11.4K |
| XTX Topco Ltd | 22,007 | $7.89K |
| Vanguard Group Inc | 18,198 | $6.51K |
| Two Sigma Investments, LP | 12,145 | $4.35K |
| Jane Street Group, LLC | 10,815 | $3.88K |
| Bank of America Corp | 180 | $65 |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 50 | $17 |
| Hantz Financial Services, Inc. | 1 | $0 |